Does New AVALON Study’s Results Strengthen the Bull Case for iRhythm Technologies (IRTC)?

iRhythm Technologies recently announced the publication of the AVALON study in the American Journal of Managed Care, which found that the Zio long-term continuous monitoring service led to faster cardiac arrhythmia diagnoses, fewer cardiovascular events, reduced healthcare utilization, and lower total healthcare costs compared to other ambulatory cardiac monitoring options in a large real-world setting. This comprehensive, independently analyzed study provides strong comparative evidence...